Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer
Clinical trial NCT01857193 · COMPLETED
Trial details
- NCT number
- NCT01857193
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-06
- Primary completion
- 2018-03-14
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.